Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers

被引：53

作者：

Pillow, Thomas H. ^{[1
]}

Schutten, Melissa ^{[1
]}

Yu, Shang-Fan ^{[1
]}

Ohri, Rachana ^{[1
]}

Sadowsky, Jack ^{[1
]}

Poon, Kirsten Achilles ^{[1
,4
]}

Solis, Willy ^{[1
,5
]}

Zhong, Fiona ^{[1
]}

Del Rosario, Geoffrey ^{[1
]}

Go, Mary Ann T. ^{[1
]}

Lau, Jeffrey ^{[1
]}

Yee, Sharon ^{[1
]}

He, Jintang ^{[1
]}

Liu, Luna ^{[1
]}

Ng, Carl ^{[1
]}

Xu, Keyang ^{[1
]}

Leipold, Douglas D. ^{[1
]}

Kamath, Amrita V. ^{[1
]}

Zhang, Donglu ^{[1
]}

Masterson, Luke ^{[2
]}

Gregson, Stephen J. ^{[2
]}

Howard, Philip W. ^{[2
]}

Fang, Fan ^{[3
]}

Chen, Jinhua ^{[3
]}

Gunzner-Toste, Janet ^{[1
]}

Kozak, Katherine K. ^{[1
]}

Spencer, Susan ^{[1
]}

Polakis, Paul ^{[1
]}

Polson, Andrew G. ^{[1
]}

Flygare, John A. ^{[1
]}

Junutula, Jagath R. ^{[1
,6
]}

机构：

[1] Genentech Inc, San Francisco, CA 94030 USA

[2] Spirogen Ltd, QMBInnovat Ctr, London, England

[3] WuXi AppTec Co Ltd, Shanghai, Peoples R China

[4] Denali Therapeut, San Francisco, CA USA

[5] Bristol Myers Squibb, Princeton, NJ USA

[6] Cellerant Therapeut, San Carlos, CA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2017年 / 16卷 / 05期

关键词：

BIOLOGICAL EVALUATION; TARGETED TREATMENT; CANCER-THERAPY; IN-VIVO; DESIGN; CHEMISTRY; SELECTION; STABILITY; LYMPHOMA; DELIVERY;

D O I：

10.1158/1535-7163.MCT-16-0641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A novel disulfide linker was designed to enable a direct connection between cytotoxic pyrrolobenzodiazepine (PBD) drugs and the cysteine on a targeting antibody for use in antibody-drug conjugates (ADCs). ADCs composed of a cysteine-engineered antibody were armed with a PBD using a self-immolative disulfide linker. Both the chemical linker and the antibody site were optimized for this new bioconjugation strategy to provide a highly stable and efficacious ADC. This novel disulfide ADC was compared with a conjugate containing the same PBD drug, but attached to the antibody via a peptide linker. Both ADCs had similar efficacy in mice bearing human tumor xenografts. Safety studies in rats revealed that the disulfide-linked ADC had a higher MTD than the peptide-linked ADC. Overall, these data suggest that the novel self-immolative disulfide linker represents a valuable way to construct ADCs with equivalent efficacy and improved safety. (C) 2017 AACR.

引用

页码：871 / 878

页数：8

共 50 条

[21] Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates
Tedeschini, T.
Campara, B.
Grigoletto, A.
Bellini, M.
Salvalaio, M.
Matsuno, Y.
Suzuki, A.
Yoshioka, H.
Pasut, G.
JOURNAL OF CONTROLLED RELEASE, 2021, 337 : 431 - 447
[22] Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates
Schuster, Sabine
Juhasz, Eva
Halmos, Gabor
Neundorf, Ines
Gennari, Cesare
Mezo, Gabor
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
[23] Site-Specific Trastuzumab Maytansinoid Antibody-Drug Conjugates with Improved Therapeutic Activity through Linker and Antibody Engineering
Pillow, Thomas H.
Tien, Janet
Parsons-Reponte, Kathryn L.
Bhakta, Sunil
Li, Hao
Staben, Leanna R.
Li, Guangmin
Chuh, Josefa
Fourie-O'Donohue, Aimee
Darwish, Martine
Yip, Victor
Liu, Luna
Leipold, Douglas D.
Su, Dian
Wu, Elmer
Spencer, Susan D.
Shen, Ben-Quan
Xu, Keyang
Kozak, Katherine R.
Raab, Helga
Vandlen, Richard
Phillips, Gail D. Lewis
Scheller, Richard H.
Polakis, Paul
Sliwkowski, Mark X.
Flygare, John A.
Junutula, Jagath R.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) : 7890 - 7899
[24] Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
Weng, Weining
Meng, Tao
Zhao, Qianqian
Shen, Yi
Fu, Guoxiang
Shi, Jing
Zhang, Yue
Wang, Zhaohui
Wang, Mingqiao
Pan, Rong
Ma, Linjie
Chen, Caiwei
Wang, Lijun
Zhou, Biao
Zhang, Hui
Pu, Junyi
Zhang, Jianjian
Hu, Yi Peter
Hua, Guoqiang
Qian, Yu
Liu, Shu-Hui
Hu, Wenhao
Meng, Xun
CANCER DISCOVERY, 2023, 13 (04) : 950 - 973
[25] An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates
Ha, Summer Y. Y.
Anami, Yasuaki
Yamazaki, Chisato M.
Xiong, Wei
Haase, Candice M.
Olson, Scott D.
Lee, Jangsoon
Ueno, Naoto T.
Zhang, Ningyan
An, Zhiqiang
Tsuchikama, Kyoji
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (09) : 1449 - 1461
[26] Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging
Schumacher, Felix F.
Nunes, Joao P. M.
Maruani, Antoine
Chudasama, Vijay
Smith, Mark E. B.
Chester, Kerry A.
Baker, James R.
Caddick, Stephen
ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (37) : 7261 - 7269
[27] Development of Efficient Chemistry to Generate Site-Specific Disulfide-Linked Protein- and Peptide-Payload Conjugates: Application to THIOMAB Antibody-Drug Conjugates
Sadowsky, Jack D.
Pillow, Thomas H.
Chen, Jinhua
Fan, Fang
He, Changrong
Wang, Yanli
Yan, Gang
Yao, Hui
Xu, Zijin
Martin, Shanique
Zhang, Donglu
Chu, Phillip
dela Cruz-Chuh, Josefa
O'Donohue, Aimee
Li, Guangmin
Del Rosario, Geoffrey
He, Jintang
Liu, Luna
Ng, Carl
Su, Dian
Phillips, Gail D. Lewis
Kozak, Katherine R.
Yu, Shang-Fan
Xu, Keyang
Leipold, Douglas
Wai, John
BIOCONJUGATE CHEMISTRY, 2017, 28 (08) : 2086 - 2098
[28] Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody-Drug Conjugates for Cancer Therapy
Johan, Audrey Nathania
Li, Yi
PHARMACEUTICALS, 2022, 15 (06)
[29] A light-responsive, self-immolative linker for controlled drug delivery via peptide- and protein-drug conjugates
Zang, Chuanlong
Wang, Huawei
Li, Tiantian
Zhang, Yingqian
Li, Jiahui
Shang, Mengdi
Du, Juanjuan
Xi, Zhen
Zhou, Chuanzheng
CHEMICAL SCIENCE, 2019, 10 (39) : 8973 - 8980
[30] Chemical Modification of Linkers Provides Stable Linker-Payloads for the Generation of Antibody-Drug Conjugates
Poudel, Yam B.
Chowdari, Naidu S.
Cheng, Heng
Iwuagwu, Christiana I.
King, H. Dalton
Kotapati, Srikanth
Passmore, David
Rampulla, Richard
Mathur, Arvind
Vite, Gregory
Gangwar, Sanjeev
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (11): : 2190 - 2194

← 1 2 3 4 5 →